The antimalarial ferroquine: from bench to clinic

Ferroquine (FQ, SSR97193) is currently the most advanced organometallic drug candidate and about to complete phase II clinical trials as a treatment for uncomplicated malaria. This ferrocenecontaining compound is active against both chloroquine-susceptible and chloroquine-resistant Plasmodium falcip...

Descripción completa

Detalles Bibliográficos
Autores principales: Biot, C., Nosten, F., Fraisse, L., Ter-Minassian, D., Khalife, J., Dive, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: EDP Sciences 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671469/
https://www.ncbi.nlm.nih.gov/pubmed/21894260
http://dx.doi.org/10.1051/parasite/2011183207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671469/
https://www.ncbi.nlm.nih.gov/pubmed/21894260
http://dx.doi.org/10.1051/parasite/2011183207

Ejemplares similares